US Stock MarketDetailed Quotes

GUTS Fractyl Health

Watchlist

1.790
-0.030-1.65%

Close Dec 20 16:00 ET

1.800
+0.010+0.56%

Post 18:45 ET

86.10MMarket Cap-1.25P/E (TTM)

Fractyl Health Stock Forum

Jaguar8

Dec 12 06:03

NEWS

$Fractyl Health (GUTS.US)$
Fractyl Health Unveils Promising Preclinical Data Demonstrating Safety and Feasibility of Local Delivery of RJVA-001 Rejuva® Smart GLP-1™ Pancreatic Gene Therapy at the World Congress Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC)
Thursday, 12th December at 7:00 am
RJVA-001 was successfully delivered in large animal Yucatan pig models at low total viral dose
Results confirm ability to directly target pancreas with novel delivery catheter and rout...

Trytosaveabit

Dec 9 06:27

On watch for data release! Note the dates this week!

$Fractyl Health (GUTS.US)$ BURLINGTON, Mass., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the "Company"), a metabolic therapeutics company focused on pioneering new approaches that treat root causes of obesity and Type 2 Diabetes (T2D), today announced it will present new preclinical data from its Rejuva platform at the 2024 Poster Session of the 22nd World Congress Insulin Resistance, Diabetes & Cardiovascular Disease...

Trytosaveabit

Nov 4 15:20

Update

$Fractyl Health (GUTS.US)$ Fractyl Health: Results Show Sustained Maintenance of Weight Loss, Blood Sugar Levels at Week 13 in Dio Mice Given Rjva-001 & Continuing High Fat Diet

Jaguar8

Oct 28 22:17

Mark calendar. Presentation Nov 3 & 5 obesity related.

$Fractyl Health (GUTS.US)$
Oral Presentation
Title: Islet-Targeted GLP-1 Receptor Agonist Gene Therapy Reduces Fat and Improves Metabolism in Obese Mice
Presentation Date & Time: Tuesday, November 5, 2024, 10:45 am - 11:00 am (CDT)
Location: Henry B. Gonzalez Convention Center, Room 007
Poster Presentation
Title: Duodenal Mucosal Resurfacing Durably Maintains Weight Loss in Metabolic Disease
Presentation Date & Time: Sunday, November 3, 2024,...

Stock_Drift

Oct 28 10:08

Unusual Volume Ticks. 11:07am 10/28

$Fractyl Health (GUTS.US)$ $Pixie Dust Technologies(Delisted) (PXDT.US)$ $Oklo Inc (OKLO.US)$ $Revance Therapeutics (RVNC.US)$ $PROCEPT BioRobotics (PRCT.US)$ $Atlas Lithium (ATLX.US)$ $EyePoint Pharmaceuticals (EYPT.US)$ $Porch Group (PRCH.US)$ $Top Wealth Group Holding (TWG.US)$ $Global Mofy AI (GMM.US)$ $Monte Rosa Therapeutics (GLUE.US)$ $Evoke Pharma (EVOK.US)$ $Greenlane (GNLN.US)$ $Autonomix Medical (AMIX.US)$ $Healthcare Triangle (HCTI.US)$
📊⚡️📊

Trytosaveabit

Oct 28 06:04

Watching

$Fractyl Health (GUTS.US)$ Fractyl Health to Present Compelling Weight Maintenance Data from both Revita® and Rejuva® Platforms at ObesityWeek® 2024
2 MINUTES AGO, 7:00 AM EDT
VIA GLOBENEWSWIRE
BURLINGTON, Mass., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (NASDAQ:GUTS) (the "Company"), a metabolic therapeutics company focused on pioneering new approaches that treat root causes of obesity and Type 2 Diabetes (T2D), today announced that it will present compelling weight maintena...

Stock_Drift

Oct 1 17:14

After hours Ticks, 5:12pm EST.

$S&W Seed (SANW.US)$ $Fractyl Health (GUTS.US)$ $Volcon (VLCN.US)$ $Eterna Therapeutics (ERNA.US)$ $Lazydays (GORV.US)$ $Adagio Medical (ADGM.US)$ $EXCELFIN ACQUISITION CORP (XFIN.US)$ $Treasure Global (TGL.US)$ $HWH International (HWH.US)$ $iCoreConnect (ICCT.US)$
📊⚡️📊

Trytosaveabit

Aug 8 07:29

Update

$Fractyl Health (GUTS.US)$ Fractyl Health Announces Clinical Results from German Real-World Registry Showing Meaningful and Sustained Weight Loss for at Least One Year After a Single Revita Endoscopic Procedure
Globe Newswire 8-Aug-2024

Trytosaveabit

Jul 30 06:04

Update

$Fractyl Health (GUTS.US)$ Reuters· 3 mins ago
Fractyl Health Receives FDA Breakthrough Device Designation for Revita in Weight Maintenance for People With Obesity Who Discontinue GLP-1 Based Drugs